Results 251 to 260 of about 154,315 (305)
Improving Automatic Coronary Stenosis Classification Using a Hybrid Metaheuristic with Diversity Control. [PDF]
Gil-Rios MA +4 more
europepmc +1 more source
Cardiac stalling: Modelling energy balance in aortic stenosis and its role in syncope
The Journal of Physiology, EarlyView.
DeWayne Townsend
wiley +1 more source
ABSTRACT Background Primary aldosteronism (PA) has been linked with reduced health‐related quality of life (QoL) and increased prevalence of anxiety and depression. While most studies compared patients with PA to healthy subjects, this study focused on comparison with hypertensive patients without PA to identify PA‐specific effects.
Sybille Fuld +15 more
wiley +1 more source
Takayasu's arteritis causing coronary stenosis with myocardial ischemia, severe aortic regurgitation, and pericarditis. [PDF]
Álvarez Vázquez A +8 more
europepmc +1 more source
Biallelic SLC20A1 loss‐of‐function variant causes a previously unrecognized multisystem developmental disorder. We report the first homozygous case presenting with tetralogy of Fallot, renal agenesis, polydactyly, and growth impairment. Transcriptome analysis of patient‐derived fibroblasts suggests significant dysregulation of pathways critical for ...
Eugénie Koumakis +9 more
wiley +1 more source
A Case of the Uncommon Cause of Chronic Coronary Syndrome: Coronary Fistula and Coronary Stenosis, Which One to Intervene? [PDF]
Sinurat MRMP +4 more
europepmc +1 more source
Abstract Aims Patients with myocardial infarction with non‐obstructive coronary arteries (MINOCA) may be affected by coronary microvascular dysfunction with reduced stress perfusion. Changes in native T1 and T2 reflect changes in myocardial perfusion; therefore, the aim of our study was to investigate whether non‐contrast, adenosine stress native T1 ...
Daniel F. Andersson +4 more
wiley +1 more source
Impact of Wood Smoke Exposure on Aortic Valve Mineralization: Microvesicles as Mineral Conveyors in Patients with Coronary Stenosis. [PDF]
Flores-García M +10 more
europepmc +1 more source
A nano‐interception strategy disrupts pathogenic fibroblast–macrophage crosstalk in chronic heart failure. Scalable Prussian blue nanoparticles selectively sequester CCL2 via ultrahigh‐affinity binding, preventing CCR2+ macrophage recruitment and breaking a key fibro‐inflammatory circuit. This approach demonstrates robust efficacy in murine and porcine
Bo Chen +16 more
wiley +1 more source

